Home page > Medicines, health technology and health information

complementary and alternative medicine

Please find all related articles below.

’Freedom of no choice’? Discussing the availability of CAM products in Europe

The most recent meeting of the MEP Interest Group on Complementary and Alternative Medicine (CAM) took place on 1 July 2015 at the European Parliament. Hosted by MEP Sirpa Pietikaeinen (EPP, Finland), it focused on the gap in availability of CAM products and treatments in many EU Member States. To kick off the meeting, MEP Sirpa Pietikaeinen recalled that a large number of people in Europe - currently estimated to be about 50% of the population - have already used CAM products, which (...)

AMR’s multiple dimensions call for action on all fronts

The June Uppsala Health Summit (UHS), ‘A World Without Antibiotics’ expanded the discussion about antimicrobial resistance (AMR) at European and national level by examining this critical health threat from different angles. Among the key themes discussed were access to antibiotics and to improved diagnostics, the environmental dimension of AMR, collaborative research & innovation, and economic models allowing pharma companies to balance profits and investments for the public (...)

Call to EU Ministers of Health and pharma CEOs on access to new Hepatitis C treatment

European AIDS Treatment Group and its members call on the pharmaceutical industry, governments and policy makers to show their commitment to improving access to a new Hepatitis C virus (HCV) drug. Worldwide, about 150 million people suffer from chronic HCV. In 2010, HCV related mortality in the European Union was estimated at 57,000 with rates increasing. Hepatitis C is prevalent among people who inject drugs, patients after transfusions and health professionals. A new revolutionary (...)

Food and agriculture priorities of the Italian Presidency of the EU

The Italian Presidency of the European Union has announced its political priorities in the field of food and agriculture to be focused on during the second part of 2014. Organic farming, a merger of the EU School Fruit and School Milk Scheme, works on the genetically modified organisms (GMOs) legislation, EU animal and plant health, as well as implications from the Transatlantic Trade and Investment Partnership (TTIP) top the Italian agenda. EPHA has been actively following the TTIP (...)

Keeping Antimicrobial Resistance (AMR) on the radar screen, year-round

The global problem of Antimicrobial Resistance (AMR) demands the continuous attention of the public health community beyond the annual focus of the European Antibiotic Awareness Day (marked annually on 18 November). EPHA is committed to raising awareness of AMR-related concerns, including the reduction of antibiotics use, to ensure that people living in Europe can continue to benefit from life-saving antibiotics. Moreover, it is important to promote policy coherence, as well as effective, (...)

EPHA Working Group on Complementary & Alternative Medicine (CAM)

Please find below information on the EPHA Working Group on Complementary and Alternative Medicine (CAM), which met for the first time in January 2013. All interested EPHA members are welcome to join the group regardless of whether or not they are actively working on CAM issues. The Working Group on CAM falls under EPHA’s Strategic Aim 2 on Health Systems, which covers issues related to health professionals, health threats and communicable diseases, healthcare services / health (...)

CAMbrella urges coordinated approach to Complementary & Alternative Medicine (CAM) research

The final CAMbrella conference took place on 29 November 2012, showcasing the fruit of the 3-year pan-European CAM research project - the long-awaited ’’Roadmap for European CAM Research’’ that includes the findings of the work packages and provides conclusions and recommendations for a future research agenda. To kick off the conference, Dr. Wolfgang Weidenhammer, CAMbrella project coordinator based at University of Munich, recalled that CAMbrella is a so-called (...)

Post-event Press Release & Reporting - Complementary & Alternative Medicine: Innovation and Added Value for European Healthcare

Brussels – On 9 October 2012, European Parliament Members of the European Parliament, health professionals, patients and policy makers gathered in the European Parliament to hear and debate presentations on the innovative added value of Complementary and Alternative Medicine (CAM) for European Healthcare. The potential that CAM has to maintain health, prevent ill health, promote healthier lifestyles and contribute to the sustainability of health systems should not be disregarded by (...)

Save The Date! Complementary and Alternative Medicine - Innovation and Added Value for European Healthcare

**updated** THIS EVENT IS FULL! Commissioner Dalli confirmed to deliver a video message. A conference and exhibition on the theme of ‘Complementary and Alternative Medicine - Innovation and Added Value for European Healthcare’ will take place at the Brussels offices of the European Parliament on Tuesday 9th October. The conference has been organised by the European stakeholder group for Complementary and Alternative Medicine (EUROCAM), with a support from EPHA and kindly (...)

What is Complementary and Alternative Medicine (CAM)?

Complementary and Alternative Medicine’s (CAM) CAM’s twin objectives are to maintain health and to treat illness in an individualised way where the focus is on ‘salutogenesis’ identifying and supporting the factors that maintain good health. CAM straddles the gap between prevention - and the management and treatment interventions of conventional medicine. CAM is inherently geared to: fostering good health strengthening health for resistance to health threats (...)